Latest Breaking News On - Acute graft versus host disease - Page 4 : comparemela.com

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Patrick malloyInnisfree ma incorporatedExchange commissionComputershare trust companyIronwood pharmaceuticals incVectivbio holding ag nasdaqBio extraordinary general meetingShareholders approved allIronwood pharmaceuticalsEastern timePaying agentInformation agentAcute graft versus host diseaseInherited metabolic diseasesTender offer statementRecommendation statement

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals

BASEL, Switzerland, June 26, 2023 (GLOBE NEWSWIRE) VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditi.

Patrick malloyComputershare trust companyIronwood pharmaceuticals incExchange commissionVectivbio holding ag nasdaqInnisfree ma incorporatedIronwood pharmaceuticalsEastern timePaying agentInformation agentAcute graft versus host diseaseInherited metabolic diseasesTender offer statementRecommendation statementAnnual report

Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio

Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, and VectivBio Holding AG , a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for. | June 16, 2023

United statesIronwood pharmaceuticals nasdaqIronwood pharmaceuticals incComputershare trust companyDrug administrationExchange commissionInnisfree ma incorporatedIronwood pharmaceuticalsVectivbio holding ag nasdaqVectivbio holdingHart scott rodino antitrust improvements actEastern timePaying agentInformation agentAcute graft versus host diseaseInherited metabolic diseases

Ironwood Pharmaceuticals, Inc : Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio

Ironwood Pharmaceuticals, Inc : Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesBeth calitriMatt roacheGreg martiniPatrick malloyVectivbio holding ag nasdaqIronwood pharmaceuticalsInnisfree ma incorporatedIronwood pharmaceuticals incIronwood pharmaceuticals nasdaqExchange commissionDrug administrationComputershare trust companyVectivbio holdingHart scott rodino antitrust improvements actEastern time

Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisit

BOSTON & BASEL, Switzerland (BUSINESS WIRE) Ironwood Pharmaceuticals, Inc. (“Ironwood”) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointes.

United statesBeth calitriMatt roacheGreg martiniExchange commissionInnisfree ma incorporatedDrug administrationIronwood pharmaceuticals nasdaqVectivbio holding ag nasdaqIronwood pharmaceuticals incIronwood pharmaceuticalsComputershare trust companyVectivbio holdingHart scott rodino antitrust improvements actEastern timePaying agent